Patents by Inventor Eva Tomas Falco

Eva Tomas Falco has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of treatment using a pentapeptide derived from the C-Terminus of Glucagon-Like Peptide 1 (GLP-1)
    Patent number: 10137171
    Abstract: Methods of treating obesity, metabolic syndrome, hepatic and non-hepatic steatosis, and diabetes using a pentapeptide, LVKGRamide, derived from the C-terminus of Glucagon-Like Peptide 1 (GLP-1).
    Type: Grant
    Filed: January 19, 2017
    Date of Patent: November 27, 2018
    Assignee: The General Hospital Corporation
    Inventors: Joel F. Habener, Eva Tomas-Falco
  • C-terminal fragments of glucagon-like peptide-1 (GLP-1)
    Patent number: 10118955
    Abstract: C-Terminal Fragments of Glucagon-Like Peptide-1 (GLP 1), and methods of use thereof, e.g., for the treatment of obesity and obesity-related disorders, e.g., diabetes and the metabolic syndrome.
    Type: Grant
    Filed: November 12, 2014
    Date of Patent: November 6, 2018
    Assignee: The General Hospital Corporation
    Inventors: Joel F. Habener, Tatsuya Yano, Eva Tomas Falco
  • Methods of Treatment Using A Pentapeptide Derived From The C-Terminus Of Glucagon-Like Peptide 1 (GLP-1)
    Publication number: 20170136095
    Abstract: Methods of treating obesity, metabolic syndrome, hepatic and non-hepatic steatosis, and diabetes using a pentapeptide, LVKGRamide, derived from the C-terminus of Glucagon-Like Peptide 1 (GLP-1).
    Type: Application
    Filed: January 19, 2017
    Publication date: May 18, 2017
    Inventors: Joel F. Habener, Eva Tomas-Falco
  • Methods for treating steatotic disease
    Patent number: 9040481
    Abstract: Methods for treating fatty liver disease, e.g., hepatic steatosis, using peptide fragments of the C-terminal end of glucagon-like peptide-1 (GLP-1), e.g., GLP-1(28-36).
    Type: Grant
    Filed: November 2, 2011
    Date of Patent: May 26, 2015
    Assignee: The General Hospital Corporation
    Inventors: Joel F. Habener, Eva Tomas-Falco
  • C-Terminal Fragments of Glucagon-Like Peptide-1 (GLP-1)
    Publication number: 20150133384
    Abstract: C-Terminal Fragments of Glucagon-Like Peptide-1 (GLP 1), and methods of use thereof, e.g., for the treatment of obesity and obesity-related disorders, e.g., diabetes and the metabolic syndrome.
    Type: Application
    Filed: November 12, 2014
    Publication date: May 14, 2015
    Inventors: Joel F. Habener, Tatsuya Yano, Eva Tomas Falco
  • C-terminal fragments of glucagon-like peptide-1 (GLP-1)
    Patent number: 8889618
    Abstract: C-Terminal Fragments of Glucagon-Like Peptide-1 (GLP 1), and methods of use thereof, e.g., for the treatment of obesity and obesity-related disorders, e.g., diabetes and the metabolic syndrome.
    Type: Grant
    Filed: November 9, 2009
    Date of Patent: November 18, 2014
    Assignee: The General Hospital Corporation
    Inventors: Joel F. Habener, Tatsuya Yano, Eva Tomas Falco
  • Methods of Treatment Using A Pentapeptide Derived From The C-Terminus Of Glucagon-Like Peptide 1 (GLP-1)
    Publication number: 20140212472
    Abstract: Methods of treating obesity, metabolic syndrome, hepatic and non-hepatic steatosis, and diabetes using a pentapeptide, LVKGRamide, derived from the C-terminus of Glucagon-Like Peptide 1 (GLP-1).
    Type: Application
    Filed: July 5, 2012
    Publication date: July 31, 2014
    Applicant: THE GENERAL HOSPITAL CORPORATION
    Inventors: Joel F. Habener, Eva Tomas-Falco
  • METHODS FOR TREATING STEATOTIC DISEASE
    Publication number: 20130288961
    Abstract: Methods for treating fatty liver disease, e.g., hepatic steatosis, using peptide fragments of the C-terminal end of glucagon-like peptide-1 (GLP-1), e.g., GLP-1(28-36).
    Type: Application
    Filed: November 2, 2011
    Publication date: October 31, 2013
    Applicant: THE GENERAL HOSPITAL CORPORATION
    Inventors: Joel F. Habener, Eva Tomas-Falco
  • C-Terminal Fragments of Glucagon-Like Peptide-1 (GLP-1)
    Publication number: 20110274747
    Abstract: C-Terminal Fragments of Glucagon-Like Peptide-1 (GLP 1), and methods of use thereof, e.g., for the treatment of obesity and obesity-related disorders, e.g., diabetes and the metabolic syndrome.
    Type: Application
    Filed: November 9, 2009
    Publication date: November 10, 2011
    Applicant: THE GENERAL HOSPITAL CORPORATION
    Inventors: Joel F. Habener, Tatsuya Yano, Eva Tomas Falco